Fundz

Tvardi Therapeutics, Inc. reported raising $3.15 Million in an initial SEC Form D filing, from an offering of $5 Million

PRIVATEJun 08, 2018$3.1M of $5M raised

Amount Raised

$3.15 Million

$3.15 Million sold, per SEC Form D (first sale Jun 8, 2018)

Round Type

Seed

HoustonHealthcare

Quick answer

Tvardi Therapeutics, Inc. raised $3.15 Million in a Seed round, dated June 8, 2018. Tvardi Therapeutics, Inc. is based in Houston, Texas, United States.

How much did Tvardi Therapeutics, Inc. raise?
Tvardi Therapeutics, Inc. raised $3.15 Million in a Seed round on June 8, 2018.
What does Tvardi Therapeutics, Inc. do?
Tvardi is a privately held, clinical-stage biopharmaceutical company developing small molecule inhibitors of STAT3, a key regulatory protein positioned at the intersection of many signaling pathways integral to the..
Where is Tvardi Therapeutics, Inc. based and how big is it?
Tvardi Therapeutics, Inc. is based in Houston, Texas, United States.
Who are the decision-makers at Tvardi Therapeutics, Inc?
Fundz holds 1 contact at Tvardi Therapeutics, Inc., including the Chief Medical Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Tvardi Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • CareView Communications Inc raised $1M (Seed) on July 23, 2018.
  • NANNOCARE INC raised $250K on July 23, 2018.
  • MedAware Systems, Inc. raised $45K (Seed) on July 23, 2018.
  • ProVerde Laboratories, Inc. raised $2.1M (Seed) on July 23, 2018.
  • Kypha Inc. raised $950K (Seed) on July 20, 2018.
  • Brownsville Surgicenter, LLC raised $630K (Seed) on July 20, 2018.

Who to call at Tvardi Therapeutics, Inc., and when

A new round usually means Tvardi Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Tvardi Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Tvardi Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Tvardi Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Tvardi Therapeutics, Inc.

Location

7000 FANNIN STREET

Houston, Texas, United States

About

Tvardi is a privately held, clinical-stage biopharmaceutical company developing small molecule inhibitors of STAT3, a key regulatory protein positioned at the intersection of many signaling pathways integral to the survival and immune evasion of cancer cells. STAT3 also plays a central role in the pathogenesis of many inflammatory and fibrotic diseases. Early clinical studies have shown that the company’s lead asset, TTI-101, is well-tolerated and has clinical activity across a broad range of tumors. To learn more, visit www.tvardi.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Tvardi Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJohn K., Chief Medical OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Tvardi Therapeutics, Inc.'s next move

See what Strategic adds

Tvardi Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.